Home > A European Network of Excellence in hematology.

A European Network of Excellence in hematology.

Determined to accelerate access to novel therapies supported by big data technologies.

 

We are bringing together key stakeholders from a broad spectrum of disciplines from 11 European countries. Expertise is drawn from academic institutions, national clinical disease networks, European organizations, patient advocacy groups, clinicians, and pharmaceutical companies, as well as regulatory agencies, experts in economics and ethics, and information and technology (ICT) specialists.

Agencia Española del Medicamento y Productos Sanitarios (AEMPS)

Spain

Alma Mater Studiorum - Università di Bologna (UNIBO)

Italy

AMGEN

Belgium

Assistance Publique - Hôpitaux de Paris (AP-HP)

France

Barts Health NHS Trust (BHT)

UK

BAYER

Germany

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)

Germany

CELGENE

Switzerland

ELN Foundation (ELN)

Germany

Erasmus Universiteit Medisch Centrum Rotterdam (EMC)

The Netherlands

European Alliance for Personalised Medicine (EAPM)

Belgium

European Hematology Association (EHA)

The Netherlands

European Organisation for Research and Treatment of Cancer (EORTC)

Belgium

European Research Initiative on CLL e.v. (ERIC)

Italy

European Society for Blood and Marrow Transplantation (EBMT)

The Netherlands

Flanders Institute of Biotechnology (VIB)

Belgium

Fondazione Italiana per lo studio delle sindromi mielodisplastiche onlus (FISMonlus)

Italy

Fundacio privada Institut D’investigacio Oncologica de Vall-Hebron (VHIO)

Spain

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León - IBSAL (IECSCYL-IBSAL)

Spain

Fundación para la Investigación del Hospital Universitario La Fe de la Comunidad Valenciana (HULAFE)

Spain

Genome Research Limited (GRL-SANGER)

UK

German Society of Pediatric Oncology-Hematology GmbH gemeinnützig (GPOH)

Germany

GMV Soluciones Globales Internet S.A.U. (GMV)

Spain

Goethe University Frankfurt (GUF)

Germany

Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)

France

Groupe Francophone des Myélodysplasies (GFM)

France

Heinrich-Heine-Universitaet - Duesseldorf (UDUS)

Germany

Jose Carreras Leukaemia Research Institute (IJC)

Spain

JPNV-JANSSEN

Belgium

LeukaNET (LeNET)

Germany

Ludwig-Maximilians-Universitaet - Muenchen (LMU-Muenchen)

Germany

Masaryk University (MU)

Czech Rep

MediSapiens Ltd (MS)

Finland

Medizinische Universitaet - Wien (MUW)

Austria

MENARINI

Italy

MLL Munich Leukemia Laboratory GmbH (MLL)

Germany

National Institute for Health and Care Excellence (NICE)

UK

NOVARTIS

Switzerland

Ospedale Pediatrico Bambino Gesù (OPBG)

Italy

Synapse Research Management Partners (SYNAPSE)

Spain

TAKEDA

UK

The Chancellor, Masters and Scholars of the University of Cambridge (UCAM)

UK

The Lymphoma Scientific Association (LYSA)

France

Università degli Studi di Torino (UNITO)

Italy

Universitaet Ulm (UULM)

Germany

University of Helsinki (UH)

Finland

University of Navarra (UNAV)

Spain

University of Newcastle upon Tyne (UNEW)

UK

University of Rome “Tor Vergata” (URTV)

Italy

University of York (UoY)

UK

VU University Medical Center (VUmc)

The Netherlands